Back to the main directory
Press Release
- Revive Therapeutics Approved to Trade on the OTCQB Market by GlobeNewsWire
- MEXCO ENERGY CORPORATION REPORTS FINANCIAL RESULTS FOR FISCAL 2021 by GlobeNewsWire
- Report - Erytech’s Combined Shareholders’ Meeting on June 25, 2021 by GlobeNewsWire
- Hepion Pharmaceuticals Announces Adjournment of Annual Meeting by GlobeNewsWire
- Acuity Brands Declares Quarterly Dividend by GlobeNewsWire
- Seabridge Gold Reports on Results of Annual Meeting of Shareholders by Newsfile Corp.
- AutoZone Announces Senior Vice President Promotions by GlobeNewsWire
- ERES REIT Kick Starts 2021 Growth With Two Multi-Residential Acquisitions in the Netherlands for Combined €47MM by GlobeNewsWire
- Synchronoss Technologies, Inc. Umumkan Rencana Penawaran Publik atas Senior Notes Sebesar $120 Juta by GlobeNewsWire
- Synchronoss Technologies, Inc. kündigt öffentliches Angebot von vorrangigen Schuldverschreibungen im Wert von 120 Mio. US-Dollar an by GlobeNewsWire
- シンクロノス･テクノロジーズ、1億2,000万ドル (約132億円) の優先債の募集提案を発表 by GlobeNewsWire
- Synchronoss Technologies, Inc. Mengumumkan Cadangan Penawaran Awam $120 Juta bagi Nota Kanan by GlobeNewsWire
- Synchronoss Technologies, Inc.宣布拟公开发行1.2亿美元优先票据 by GlobeNewsWire
- Synchronoss Technologies, Inc. 宣佈計劃公開發行 1.2 億美元優先票據 by GlobeNewsWire
- L’engagement du CN à garder ouverts les points d’entrée dans le regroupement CN-KCS assure aux clients du secteur céréalier, y compris ceux du Haut-Midwest américain, l’accès concurrentiel voulu by GlobeNewsWire
- Arbutus Announces New Data on AB-729 and AB-836 Programs with Presentation of Five Abstracts at the EASL International Liver Congress™ 2021 - All Selected for Best of ILC™ by GlobeNewsWire
- Festi hf.: Endurkaup vika 42 by GlobeNewsWire
- Orphazyme announces restructuring to focus resources on supporting a path forward for arimoclomol in NPC by GlobeNewsWire
- First Head & Neck Cancer Patient Enrolled in the UK in a Phase I Trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy by BusinessWire
- Technip Energies Announces Publication Date for First Half 2021 Financial Results and Conference Call by BusinessWire
- Dupixent® (dupilumab) SmPC updated with long-term data reinforcing well-established safety profile in adults with moderate-to-severe atopic dermatitis by GlobeNewsWire
- Mise à jour du RPC de Dupixent® (dupilumab) avec des données de long terme qui confortent son profil de sécurité bien établi chez l’adulte atteint de dermatite atopique modérée à sévère by GlobeNewsWire
- Hexagon Purus accelerates its efforts in the zero emission maritime segment by GlobeNewsWire
- Idorsia initiates the Phase 3 registration study with selatogrel for the treatment of acute myocardial infarction by GlobeNewsWire
- Eurofins to Acquire DNA Diagnostics Center to Grow Genetic Testing Capabilities and Significantly Expand Further Into the Consumer Testing Market by BusinessWire